Clincosm LogoSign in Get a demo

Leukemia, Chronic Myeloid

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Chronic Myeloid Trial in Ann Arbor, Winston-Salem (Nilotinib, Ruxolitinib)

Withdrawn
  • Leukemia, Chronic Myeloid
  • Ann Arbor, Michigan
  • +1 more
Feb 11, 2021

Leukemia, Chronic Myeloid Trial in Campinas (Pioglitazone, imatinib discontinuation)

Active, not recruiting
  • Leukemia, Chronic Myeloid
  • Campinas, SP, Brazil
    Centro de Hematologia e Hemoterapia - Universidade Estadual de C
Nov 2, 2020

Leukemia, Chronic Myeloid Trial in Malaysia (Peginterferon-a-2a)

Active, not recruiting
  • Leukemia, Chronic Myeloid
  • Johor Bahru, Johor, Malaysia
  • +8 more
Sep 11, 2020

Leukemia, Chronic Myeloid, MDS, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Trial in Saint-Petersburg (Unrelated

Terminated
  • Leukemia, Chronic Myeloid
  • +2 more
  • Unrelated allogeneic stem cell transplantation
  • +6 more
  • Saint-Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Apr 3, 2019

Leukemia, Chronic Myeloid, Myeloid Leukemia, Chronic, Accelerated Phase, Myeloid Leukemia, Chronic, Chronic Phase Trial in Seoul

Terminated
  • Leukemia, Chronic Myeloid
  • +2 more
  • Diagnosed as CML
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 19, 2018

Leukemia, Chronic Myeloid Trial in Harbin (hydroxyurea, Imatinib)

Unknown status
  • Leukemia, Chronic Myeloid
  • Harbin, Heilongjiang, China
    the First Affiliated Hospital of Harbin Medical University
May 21, 2018

Leukemia, Chronic Myeloid Trial (Nilotinib)

Unknown status
  • Leukemia, Chronic Myeloid
  • (no location specified)
Mar 16, 2015